Insider · CIK 0002127529
Michael Cunyuan Chen
Files at SPTX (Seaport Therapeutics, Inc.). First filing -, latest -.
In brief
Michael Cunyuan Chen files SEC Form 4 as officer at SPTX (Seaport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael Cunyuan Chen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Common Stock | +3,351 | - | - | 3,351 | May 4, 2026 |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +63,680 | $0.00 | $0 | 63,680 | May 4, 2026 |
| May 4, 2026 | SPTX Seaport Therapeutics, Inc. | CConversion Series B Preferred Stockderivative | -10,526 | $0.00 | $0 | 0 | May 4, 2026 |
Questions about Michael Cunyuan Chen
Answered from the filings on this page, as of the latest one.
Is Michael Cunyuan Chen buying or selling?
Michael Cunyuan Chen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael Cunyuan Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Cunyuan Chen has 0.
Where does Michael Cunyuan Chen file Form 4?
Michael Cunyuan Chen has filed Form 4 at SPTX (Seaport Therapeutics, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.